openPR Logo
Press release

Global Congestive Heart Failure Drugs Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028

05-25-2022 12:26 PM CET | Health & Medicine

Press release from: Orion Market Reports

The congestive heart failure drugs market is anticipated to grow at a significant CAGR of 16.1% during the forecast period (2022-2028). Some of the congestive heart failure drugs such as angiotensin-converting enzyme inhibitors are given in a state of congestive heart failure. This works by relaxing the blood vessels of the heart. Some angiotensin-converting enzyme inhibitors are ramipril, enalapril, and lisinopril. Angiotensin-2 receptor blockers are also used to relax blood vessels of the heart and some of them are valsartan and candesartan. An increase in the number of heart failure patients is the major factor that has surged the demand for such drugs and the heart failure prevalence is expected to drive the market during the forecast period. For instance, in June 2020,as per an article published in the AME Medical Journal, there were around 64.34 million cases of Heart Failure in the world.

A full report of Global Congestive Heart Failure Drugs Market is available at:https://orionmarketreports.com/global-congestive-heart-failure-drugs-market/109560/  

Some major players operating in the congestive heart failure drugs market include Amgen Inc, Glaxo SmithKline Plc, Pfizer Inc, Teva Pharmaceutical Industries Ltd. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in May 2020, Food and Drug Administration has approved the Farxiga drug which is useful in the treatment of congestive heart failure. This drug is manufactured by AstraZeneca Pharmaceuticals LP. This drug has been found effective in reducing the ejection fraction and decreasing the risk of hospitalization and death in case of heart failure. This drug belongs to a class of sodium-glucose co-transporter 2 inhibitors.

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Drug Type
By End-User
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape-Amgen Inc, Glaxo Smith Kline Plc, Pfizer Inc, Teva Pharmaceutical Industries Ltd.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Congestive Heart Failure Drugs MarketReport by Segment

By Drug Type

ACE Inhibitors
Angiotensin 2 Receptor Blockers
Beta Blockers
Mineral corticoid Receptor Antagonists
Diuretics
Ivabradine
Sacubritil Valsartan
Hydralazine With Nitrate
Digoxin

By End-User

Hospital
Clinic
Others

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Congestive Heart Failure Drugs Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here

News-ID: 2635925 • Views:

More Releases from Orion Market Reports

Module Power Supply Market to see Huge Growth by 2031
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations
Plasma Spray Guns Market to see Rapid Growth by 2031
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma
Plasma Torch Market Value Projected to Expand by 2031
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase